Stock Screener App

무료 -

설치하다

62.95

1.22% 0.76

after-market

시간 외 거래: 62.85 -0.10 -0.16%

Cytokinetics Inc (CYTK)

개요 뉴스 가격 이력 옵션 체인 Financials CYTK 왜 하락? 토론 예측 주식 분할

Cytokinetics Inc 주식(CYTK)의 최신 뉴스

Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CY - GuruFocus

Sung Lee Sells 4,935 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 1,930 Shares of Stock - MarketBeat

Blum, Cytokinetics CEO, sells $2.2m in shares By Investing.com - Investing.com Canada

Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 36,601 Shares of Stock - MarketBeat

Fady Ibraham Malik Sells 12,033 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Andrew Callos Sells 8,542 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Malik Fady Ibraham sells Cytokinetics (CYTK) stock worth $747,850 - Investing.com

Cytokinetics Insiders Sold Shares Worth Over $3.6M - TradingView

Cytokinetics (CYTK) CFO share sale covers RSU tax obligations - Stock Titan

Mizuho Raises Price Target for Cytokinetics (CYTK) to $100 | CYT - GuruFocus

Cytokinetics (CYTK) EVP executes 8,542-share sell-to-cover for RSU taxes - Stock Titan

[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan

Cytokinetics President & CEO Sold Shares Worth Over $2.2M - TradingView

Cytokinetics (CYTK) CEO executes sell-to-cover stock sales for taxes - Stock Titan

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Cytokinetics gives 5 new hires options, RSUs under Nasdaq rule - Stock Titan

Mizuho Boosts Cytokinetics (NASDAQ:CYTK) Price Target to $100.00 - MarketBeat

New Aficamten HCM Data On Exercise Capacity And Flexibility Might Change The Case For Investing In Cytokinetics (CYTK) - simplywall.st

Cytokinetics (CYTK) CEO receives new RSU and stock option awards - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Cytokinetics (CYTK) EVP awarded new stock options and RSUs - Stock Titan

Cytokinetics (CYTK) awards stock options and RSUs to chief legal officer - Stock Titan

Cytokinetics (CYTK) CFO granted RSUs and stock options - Stock Titan

JPMorgan Chase & Co. Raises Cytokinetics (NASDAQ:CYTK) Price Target to $75.00 - MarketBeat

CYTK Analyst Update: JP Morgan Raises Price Target to $75 | CYTK Stock News - GuruFocus

Cytokinetics stock price target raised to $75 by JPMorgan - Investing.com Canada

JPMorgan Boosts Price Target on Cytokinetics (CYTK) Amid Positive Outlook - GuruFocus

Granahan Investment Management LLC Purchases Shares of 53,550 Cytokinetics, Incorporated $CYTK - MarketBeat

Bamco Inc. NY Makes New Investment in Cytokinetics, Incorporated $CYTK - National Today

Assessing Cytokinetics (CYTK) Valuation After New MYQORZO Trial Data And Safety Outcomes - Yahoo Finance

Cytokinetics MYQORZO Data Sheds Light On oHCM Outlook And Valuation - simplywall.st

Cytokinetics (NASDAQ:CYTK) EVP Sells $104,300.27 in Stock - MarketBeat

Stifel reiterates Cytokinetics stock rating ahead of trial data By Investing.com - Investing.com Canada

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market - AOL.com

Cytokinetics (CYTK) Presents Findings on Aficamten for Cardiomyo - GuruFocus

Cytokinetics announces four presentations at the American College of Cardiology annual scientific session & expo - marketscreener.com

Cytokinetics Announces Four Presentations At The American College Of Cardiology Annual Scientific Session & Expo - TradingView

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual ... - nrtoday.com

Heart drug MYQORZO outperforms beta blocker in key HCM studies - Stock Titan

HighVista Strategies LLC Acquires 64,278 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat

458,295 Shares in Cytokinetics, Incorporated $CYTK Purchased by Foresite Capital Management IV LLC - MarketBeat

Cinctive Capital Management LP Takes Position in Cytokinetics, Incorporated $CYTK - MarketBeat

Cytokinetics, Incorporated $CYTK Shares Acquired by Aquatic Capital Management LLC - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cytokinetics, Incorporated (CYTK) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Boxer Capital Management LLC Acquires New Shares in Cytokinetics, Incorporated $CYTK - MarketBeat

Checkpoint Capital L.P. Invests $2.07 Million in Cytokinetics, Incorporated $CYTK - MarketBeat

Cytokinetics Highlights Early MYQORZO Momentum, Eyes Q2 nHCM Phase 3 Catalyst at Barclays Confab - MarketBeat

Cytokinetics Teases Q2 ACACIA-HCM Catalyst as MYQORZO Launch Gains Momentum at Leerink Conference - Yahoo Finance

Cytokinetics Teases Q2 Phase 3 ACACIA-HCM Readout as Myqorzo Launch Gains Traction at Citi Conference - MarketBeat

Cytokinetics, Incorporated $CYTK Shares Sold by Melqart Asset Management UK Ltd - MarketBeat

Quinn Opportunity Partners LLC Grows Stock Position in Cytokinetics, Incorporated $CYTK - MarketBeat

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pliant Therapeutics (PLRX) and Cytokinetics (CYTK) - The Globe and Mail

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cytokinetics, Incorporated (CYTK) And Encourages Stockholders to Connect - ACCESS Newswire

Cytokinetics at Barclays Conference: Strategic Growth and Global Ambitions By Investing.com - Investing.com Nigeria

Cytokinetics at Barclays Conference: Strategic Growth and Global Ambitions - Investing.com Australia

Gabelli Funds LLC Boosts Position in Cytokinetics, Incorporated $CYTK - MarketBeat

Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Leerink Maintains Outperform for Cytokinetics, Incorporated (CYTK) March 2026 - Meyka

Robert Blum Sells 7,931 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 2,907 Shares of Stock - MarketBeat

Cytokinetics (CYTK) EVP Callos sells stock to cover RSU taxes - Stock Titan

Cytokinetics Leaders Gained $16 Million as Insiders, Suit Says - Bloomberg Law News

Cytokinetics at The Citizens Life Sciences Conference: Myqorzo’s Market Potential - Investing.com Canada

Leerink reiterates Cytokinetics stock rating on launch confidence By Investing.com - Investing.com Canada

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market - The Motley Fool

Cytokinetics at Leerink Global Healthcare Conference: Strategic Growth in Cardiology - Investing.com Canada

UBS Maintains Neutral on CYTK, Cytokinetics, Incorporated March 2026 - Meyka

RVMD

$99.29

1.20%

ROIV

$27.80

0.00%

MRNA

$52.37

0.06%

BNTX

$89.31

0.77%

INSM

$144.00

0.91%

ONC

$282.72

0.15%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개